Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Update on board meeting
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has updated the stock exchanges about its board meeting scheduled for January 30, 2026. The board will consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Additionally, the board will consider the declaration of a 3rd interim dividend, if any, on equity shares for the financial year 2025-26. This is a follow-up to the earlier intimation dated December 29, 2025, with the dividend agenda now added to the meeting.
Short-term positive sentiment likely as investors anticipate both Q3 results and another interim dividend, reinforcing Dr. Lal PathLabs' track record of consistent shareholder payouts. Stock may see mild interest around the results and dividend announcement date.